交易中 04-01 12:08:52 美东时间
+0.150
+1.63%
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
Roth Capital analyst Kyle Bauser reiterates InfuSystems Holdings (AMEX:INFU) with a Buy and raises the price target from $14 to $15.
02-25 22:55
InfuSystem is providing annual net revenue guidance for the full year 2026 in two parts by providing the impact of the biomedical services contract restructuring, which will reduce our net revenues by $7.1 million, or
02-24 19:36
InfuSystems Holdings (AMEX:INFU) just disclosed its Q4 earnings on Tuesday, Feb...
02-24 19:32
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026 Rochester Hills, Michigan, December 10, 2025 - InfuSystem Holdings,
2025-12-11 06:36
The latest update is out from InfuSystem Holdings ( ($INFU) ). InfuSystem Holdi...
2025-11-14 06:20
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
2025-11-06 09:55
Roth Capital analyst Kyle Bauser reiterates InfuSystems Holdings (AMEX:INFU) with a Buy and raises the price target from $13 to $14.
2025-11-06 01:55
An announcement from InfuSystem Holdings ( ($INFU) ) is now available. InfuSyst...
2025-10-07 05:51